The former head of FDA’s orphan drug office petitioned the agency Friday (Feb. 25) to stop reviewing drugs and devices developed by Russian companies in light of Russia’s invasion of Ukraine. “This emergency petition requests the Commissioner immediately and completely freeze all administrative actions on any regulatory requests from pharmaceutical and medical device companies headquartered in Russia or with majority Russian ownership,” the petition states . The petition, first reported by Clinical Trials Arena, was filed by Tim Coté,...